Anti-Ischemic Activity of Fabomotizole Hydrochloride under Conditions of Endothelial Dysfunction


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Anti-ischemic activity of fabomotizole hydrochloride was studied on the model of subendocardial ischemia in rats with endothelial dysfunction. Endothelial dysfunction was modeled by intragastric administration of methionine (3 g/kg, once a day for 7 days). Acute subendocardial ischemia was induced in narcotized rats by intraperitoneal injection of isoproterenol (20 μg/kg/min over 5 min). Fabomotizole hydrochloride (intraperitoneally, 15 mg/kg) significantly reduced isoproterenol-induced ST segment depression in animals with endothelial dysfunction and with intact vasculature.

About the authors

I. B. Tsorin

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Russian Federation, Moscow

V. V. Barchukov

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Russian Federation, Moscow

M. B. Vititnova

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Russian Federation, Moscow

S. A. Kryzhanovskii

V. V. Zakusov Research Institute of Pharmacology

Author for correspondence.
Email: SAK-538@yandex.ru
Russian Federation, Moscow

S. B. Seredenin

V. V. Zakusov Research Institute of Pharmacology

Email: SAK-538@yandex.ru
Russian Federation, Moscow


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies